205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-43.71%
Both yoy net incomes decline, with QRVO at -18.40%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-184.74%
Both reduce yoy usage, with QRVO at -100.00%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
40.78%
AR growth well above QRVO's 34.56%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-1950.00%
Both reduce yoy inventory, with QRVO at -67.12%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
-109.32%
Negative yoy usage while QRVO is 100.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
108.83%
Some yoy increase while QRVO is negative at -100.00%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-23.75%
Both yoy CFO lines are negative, with QRVO at -8.15%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-7.59%
Both yoy lines negative, with QRVO at -31.67%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-0.41%
Negative yoy purchasing while QRVO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-36.40%
We reduce yoy sales while QRVO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-2323.33%
Both yoy lines negative, with QRVO at -134.85%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-75.64%
Both yoy lines negative, with QRVO at -13.26%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-3.03%
We cut yoy buybacks while QRVO is 0.15%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.